José Meneses Calderón
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
José Meneses Calderón has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Academia Mexicana de Cirugía
1 shared publicationAcademia Nacional de Medicina
1 shared publicationAlberto Ignacio Álvarez López
1 shared publication- Berenice Zavala Barrios
Secretaría de Salud (SSa). Hospital General de México “Dr. Eduardo Liceaga”. Diagnóstico y Tratamiento. Ciudad de México, México
1 shared publication Carlos Gabriel Briones Vega
1 shared publicationCelaya Hospital Materno Infantil
1 shared publication
Latest Publications
- Open Access
- 30 September 2020
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 14 (09) , 982-986
Nitazoxanide against COVID-19 in three explorative scenarios
Introduction: Nitazoxanide has shown efficacy in vitro against coronavirus infections (MERS, SARS, SARS-CoV-2). The aim of this report is to describe the results of treating COVID-19 positive patients with nitazoxanide in three clinical settings: pregnancy/puerperium, hospitalized patients in an Internal Medicine Service and in an ambulatory setting. Methodology: This was a prospective follow-up and report of COVID-19 cases in three different situations, pregnant women, hospitalized patients receiving medical attention in an Internal Medicine Service and ambulatory patients residing in Toluca City, and Mexico City. Results: The experience with a first group of 20 women, pregnant (17) or in immediate puerperium (3) was successful in 18 cases with two unfortunate deaths. The five cases treated in an Internal Medicine service showed a positive outcome with two patients weaned from mechanical ventilation. Of the remaining 16 patients treated in an ambulatory setting, all got cured. Nitazoxanide seems to be useful against SARS-CoV-2, not only in an early intervention but also in critical condition as well as in pregnancy without undesired effects for the babies. As an adjunctive therapy budesonide was used that seems to contribute to the clinical improvement. Conclusions: Nitazoxanide could be useful against COVID-19 as a safe and available regimen to be tested in a massive way immediately.
- 30 September 2020
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 14 (09) , 982-986
Open AccessNitazoxanide against COVID-19 in three explorative scenarios
Introduction: Nitazoxanide has shown efficacy in vitro against coronavirus infections (MERS, SARS, SARS-CoV-2). The aim of this report is to describe the results of treating COVID-19 positive patients with nitazoxanide in three clinical settings: pregnancy/puerperium, hospitalized patients in an Internal Medicine Service and in an ambulatory setting. Methodology: This was a prospective follow-up and report of COVID-19 cases in three different situations, pregnant women, hospitalized patients receiving medical attention in an Internal Medicine Service and ambulatory patients residing in Toluca City, and Mexico City. Results: The experience with a first group of 20 women, pregnant (17) or in immediate puerperium (3) was successful in 18 cases with two unfortunate deaths. The five cases treated in an Internal Medicine service showed a positive outcome with two patients weaned from mechanical ventilation. Of the remaining 16 patients treated in an ambulatory setting, all got cured. Nitazoxanide seems to be useful against SARS-CoV-2, not only in an early intervention but also in critical condition as well as in pregnancy without undesired effects for the babies. As an adjunctive therapy budesonide was used that seems to contribute to the clinical improvement. Conclusions: Nitazoxanide could be useful against COVID-19 as a safe and available regimen to be tested in a massive way immediately.
- 1 January 2019
- Published by Universidad Nacional Autonoma de Mexico
Medicina crítica en Obstetricia Tomo II
- 1 January 2019
- Published by Universidad Nacional Autonoma de Mexico
Medicina crítica en Obstetricia Tomo II